Frontlight ResearchEarly access
Trial site
Cattedra di Ematologia CTMO Università degli Studi di Parma
- 3closed trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Chronic lymphocytic leukaemia2 trials
- Chronic myeloid leukaemia1 trial
- Phase
- Phase 22 trials
- Status
- Completed3 trials
- Lead sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto3 trials
Closed trials
Completed
Completed
Completed
Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase
Site data: ClinicalTrials.govUpdated 12 Nov 2026